Danaher Corp. (NYSE:DHR) is scheduled to be releasing its Q316 earnings data on Thursday, October 20th. Analysts expect Danaher Corp. to post earnings of $0.82 per share and revenue of $4.14 billion for the quarter.

Danaher Corp. (NYSE:DHR) last announced its quarterly earnings results on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.03. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The company’s revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.08 EPS. On average, analysts expect Danaher Corp. to post $3.55 EPS for the current fiscal year and $3.9 EPS for the next fiscal year.

Earnings History for Danaher Corp. (NYSE:DHR)

Shares of Danaher Corp. (NYSE:DHR) opened at 75.86 on Tuesday. The firm has a 50-day moving average of $78.00 and a 200-day moving average of $76.89. Danaher Corp. has a one year low of $61.60 and a one year high of $82.64. The company has a market cap of $52.38 billion, a price-to-earnings ratio of 15.09 and a beta of 1.13.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Wednesday, September 28th. Danaher Corp.’s dividend payout ratio (DPR) is presently 9.94%.

In other Danaher Corp. news, CFO Daniel L. Comas sold 96,446 shares of the stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the transaction, the chief financial officer now directly owns 215,716 shares in the company, valued at approximately $17,447,110.08. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the transaction, the insider now owns 179,054 shares in the company, valued at $14,582,157.76. The disclosure for this sale can be found here. Company insiders own 12.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of DHR. Sei Investments Co. boosted its position in shares of Danaher Corp. by 3.5% in the second quarter. Sei Investments Co. now owns 325,506 shares of the company’s stock valued at $32,877,000 after buying an additional 11,081 shares during the last quarter. Cleararc Capital Inc. boosted its position in shares of Danaher Corp. by 0.4% in the second quarter. Cleararc Capital Inc. now owns 13,592 shares of the company’s stock valued at $1,373,000 after buying an additional 53 shares during the last quarter. Lakeview Capital Partners LLC boosted its position in shares of Danaher Corp. by 41.7% in the second quarter. Lakeview Capital Partners LLC now owns 7,704 shares of the company’s stock valued at $590,000 after buying an additional 2,268 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Danaher Corp. by 113.5% in the second quarter. Janney Montgomery Scott LLC now owns 140,878 shares of the company’s stock valued at $14,228,000 after buying an additional 74,883 shares during the last quarter. Finally, Public Sector Pension Investment Board boosted its position in shares of Danaher Corp. by 17.4% in the second quarter. Public Sector Pension Investment Board now owns 113,579 shares of the company’s stock valued at $11,471,000 after buying an additional 16,800 shares during the last quarter. Institutional investors own 75.73% of the company’s stock.

DHR has been the topic of several research analyst reports. Zacks Investment Research downgraded shares of Danaher Corp. from a “buy” rating to a “hold” rating in a report on Thursday, September 29th. Goldman Sachs Group Inc. initiated coverage on shares of Danaher Corp. in a report on Tuesday, July 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Morgan Stanley reissued a “buy” rating and issued a $86.00 target price on shares of Danaher Corp. in a report on Wednesday, August 31st. JPMorgan Chase & Co. reissued a “buy” rating and issued a $90.00 target price on shares of Danaher Corp. in a report on Thursday, October 6th. Finally, Barclays PLC reissued an “overweight” rating and issued a $86.00 target price (down previously from $105.00) on shares of Danaher Corp. in a report on Monday, July 11th. Eight equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $92.87.

About Danaher Corp.

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.

5 Day Chart for NYSE:DHR

Receive News & Stock Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related stocks with our FREE daily email newsletter.